Announcement

Collapse
No announcement yet.

Respirol Case Rep . Post-coronavirus disease 2019 organizing pneumonia confirmed pathologically by video-assisted thoracoscopic surgery

Collapse
X
 
  • Filter
  • Time
  • Show
Clear All
new posts

  • Respirol Case Rep . Post-coronavirus disease 2019 organizing pneumonia confirmed pathologically by video-assisted thoracoscopic surgery


    Respirol Case Rep


    . 2021 Oct 28;9(12):e0871.
    doi: 10.1002/rcr2.871. eCollection 2021 Dec.
    Post-coronavirus disease 2019 organizing pneumonia confirmed pathologically by video-assisted thoracoscopic surgery


    Keishi Sugino 1 , Hirotaka Ono 1 , Shuji Haraguchi 2 , Seiji Igarashi 3 , Akira Hebisawa 4 , Eiyasu Tsuboi 1



    Affiliations

    Abstract

    Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2, has become a global pandemic. Many survivors of serious COVID-19 pneumonia have long-term residual pulmonary disease. However, there is little documentation of the histopathological characteristics of lung sequelae post-COVID-19 and effective treatments. We present two Japanese cases of lung sequelae post-COVID-19. The patients were histopathologically diagnosed with organizing pneumonia (OP) or OP with fibrosis and no diffuse alveolar damage on video-assisted thoracoscopic surgery. Case 1, who had been diagnosed with OP, was successfully treated with corticosteroid and other immunosuppressive agents over a 6-month period. Although case 2, who had been diagnosed with OP with fibrosis, had a partial and unsatisfactory response to immunosuppressive agents, the patient responded to antifibrotic treatment including nintedanib.

    Keywords: coronavirus disease 2019; corticosteroid; organizing pneumonia; severe acute respiratory syndrome coronavirus 2; video‐assisted thoracoscopic surgery.

Working...
X